Stephane Bancel
Stephane Bancel is the CEO of Moderna, a biotechnology company that became widely known for its development of mRNA vaccines, particularly during the COVID-19 pandemic. Under his leadership, Moderna has been at the forefront of mRNA technology, which has shown promise in responding to various infectious diseases. Recently, Bancel commented on the termination of a $590 million contract with the U.S. Department of Health and Human Services for a bird flu vaccine, expressing disappointment but also highlighting the positive immune response observed in early trials.
Not in the pool (under ¢1).
Recent news mentions
Stéphane Bancel, the CEO of Moderna, celebrated the approval of the world's first combined vaccine against flu and Covid-19.
1ª vacina única contra Covid e gripe do mundo recebe aval para pessoas com 50 anos ou mais na Europa
Brazil· 2026-03-02Stephane Bancel, the CEO of Moderna, received an exit package worth $926m in 2019.
Christian Horner: Behind ex-Red Bull chief's pay-off, and what next?
United Kingdom· 2025-09-23
Stéphane Bancel is the Chief Executive Officer of Moderna and commented on the FDA approval of their new COVID-19 vaccine.
Coronavirus Vaccine: New COVID vaccine approved by US FDA: Here's all about it |
India· 2025-05-31Stéphane Bancel is the CEO of Moderna and commented on the robust immune response observed in a clinical trial.
L’administration Trump annule un vaste contrat pour un vaccin contre la grippe aviaire, annonce le laboratoire Moderna
France· 2025-05-29
Moderna CEO Stephane Bancel commented on the immune response of their vaccine.
HHS cancels $590 million contract with Moderna for bird flu vaccine
United States· 2025-05-29
